Targeting PDE2a to treat long-term effects of mild traumatic brain injury in soldiers

PDE2a inhibition as a therapeutic target for the chronic effects of repetitive mild TBI

NIH-funded research James a. Haley VA Medical Center · NIH-11000525

This study is looking at how blocking a specific enzyme might help soldiers who have had repeated mild brain injuries feel better and think more clearly, using mouse models to find the best ways to help them.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJames a. Haley VA Medical Center NIH-funded
Lab location1 site (Tampa, United States)
Project IDNIH-11000525 on NIH RePORTER

What this research studies

This research investigates the potential of inhibiting PDE2a as a therapeutic approach to address the chronic effects of repetitive mild traumatic brain injury (r-mTBI) experienced by soldiers. The study utilizes various mouse models to simulate the neurobehavioral and biochemical consequences of r-mTBI, aiming to identify effective treatment strategies. By understanding the molecular responses to TBI, the research seeks to develop better interventions that could improve cognitive and emotional outcomes for affected individuals. The focus is on addressing the significant burden of TBI on military personnel and their families.

Who could benefit from this research

Good fit: Ideal candidates for this research include military personnel and veterans who have experienced repetitive mild traumatic brain injuries.

Not a fit: Patients who have not experienced any form of traumatic brain injury may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly improve the quality of life for soldiers suffering from the long-term effects of mild traumatic brain injury.

How similar studies have performed: Previous research has shown promise in targeting molecular pathways related to TBI, indicating that this approach may lead to meaningful advancements in treatment.

Where this research is happening

Tampa, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.